Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

This article describes the global epidemiology of tuberculosis and reviews recent estimates of tuberculosis incidence and mortality in the world. The highest prevalence of tuberculosis infection and estimated annual risk of tuberculosis infection are in sub-Saharan Africa and Southeast Asia. Overall, almost 3.8 million cases of tuberculosis were reported in the world in 1990, of which 49% were in Southeast Asia. From the period 1984 through 1986 to the period 1989 through 1991, notification rates increased in all World Health Organization regions, except the American and the European regions. In 1990, there were an estimated 7.5 million cases of tuberculosis and 2.5 million deaths worldwide. The human immunodeficiency virus epidemic is causing increases in the number of tuberculosis cases, particularly in Africa, although increases are also expected in Southeast Asia. In many industrialized countries, tuberculosis has recently failed to decline, and in eastern Europe and the former Soviet Union, cases and deaths are increasing. Drug resistance is a serious problem, especially in the United States. If worldwide control of tuberculosis does not improve, 90 million new cases and 30 million deaths are expected in the decade 1990 through 1999.

[1]  A. Khomenko,et al.  Tuberculosis trends in eastern Europe and the former USSR. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  D. Snider,et al.  Epidemiology of tuberculosis in the United States, 1985 through 1992. , 1994, JAMA.

[3]  D Alland,et al.  Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. , 1994, The New England journal of medicine.

[4]  T. Frieden,et al.  Tuberculosis transmission in the 1990s. , 1994, The New England journal of medicine.

[5]  G. Schoolnik,et al.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.

[6]  M. Raviglione,et al.  Global tuberculosis incidence and mortality during 1990-2000. , 1994, Bulletin of the World Health Organization.

[7]  M. Diomande,et al.  The mortality and pathology of HIV infection in a West African city , 1993, AIDS.

[8]  D. Podzamczer,et al.  A prospective study of the risk of tuberculosis among HIV‐infected patients , 1993, AIDS.

[9]  W. Lew,et al.  The sixth Nationwide Tuberculosis Prevalence Survey in Korea, 1990. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  A. Kritski,et al.  HIV infection in 567 active pulmonary tuberculosis patients in Brazil. , 1993, Journal of acquired immune deficiency syndromes.

[11]  Snider De,et al.  Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. , 1993 .

[12]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[13]  L. Ackerson,et al.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. , 1993, The New England journal of medicine.

[14]  T. Frieden,et al.  The emergence of drug-resistant tuberculosis in New York City. , 1993, The New England journal of medicine.

[15]  A. Kritski,et al.  Tuberculosis y co-infeccion por vih , 1993 .

[16]  A. Kochi,et al.  Multidrug-resistant tuberculosis and its control. , 1993, Research in microbiology.

[17]  M. Raviglione,et al.  Secular trends of tuberculosis in western Europe. , 1993, Bulletin of the World Health Organization.

[18]  M. Raviglione,et al.  HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. , 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  K. Kerlikowske,et al.  Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. , 1992, The American review of respiratory disease.

[20]  P. Selwyn,et al.  High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. , 1992, JAMA.

[21]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[22]  D. Mathai,et al.  Clinical and laboratory profile of AIDS in India. , 1992, Journal of acquired immune deficiency syndromes.

[23]  A. Kochi,et al.  Tuberculosis: a global overview of the situation today. , 1992, Bulletin of the World Health Organization.

[24]  P. Cullinan,et al.  Deaths in adults with notified pulmonary tuberculosis 1983-5. , 1991, Thorax.

[25]  S. Carbonara,et al.  Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients , 1991, The Lancet.

[26]  M. Lafontaine,et al.  Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. , 1991, BMJ.

[27]  J. Ellner,et al.  The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. , 1991, The American review of respiratory disease.

[28]  R. Hayes,et al.  Impact of HIV on tuberculosis in Zambia: a cross sectional study. , 1990, BMJ.

[29]  J. Jessurun,et al.  Comparative demographic and autopsy findings in acquired immune deficiency syndrome in two Mexican populations. , 1990, Journal of acquired immune deficiency syndromes.

[30]  C. Murray,et al.  Tuberculosis in developing countries: burden, intervention and cost. , 1990, Bulletin of the International Union against Tuberculosis and Lung Disease.

[31]  M. Bakari,et al.  Survival time of patients with acquired immune deficiency syndrome: experience with 274 patients in Dar-es-Salaam. , 1990, East African medical journal.

[32]  R. Luzzati,et al.  NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.

[33]  V. Robertson,et al.  Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  D. Snider,et al.  Epidemiology of tuberculosis in the United States. , 1989, Epidemiologic reviews.

[35]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[36]  Rene,et al.  The White Plague: Tuberculosis, Man and Society , 1987 .

[37]  J. Pape,et al.  The acquired immunodeficiency syndrome in Haiti. , 1985 .

[38]  J. Darbyshire,et al.  Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. , 1984, British journal of diseases of the chest.

[39]  A. Rouillon,et al.  II. Estimated global incidence of smear-positive pulmonary tuberculosis. Unreliability of officially reported figures on tuberculosis. , 1981 .

[40]  I Sutherland,et al.  Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. , 1976, Advances in tuberculosis research. Fortschritte der Tuberkuloseforschung. Progres de l'exploration de la tuberculose.

[41]  V. Springett.  Ten-year results during the introduction of chemotherapy for tuberculosis. , 1971, Tubercle.

[42]  K. Stýblo,et al.  [The transmission of tubercle bacilli: its trend in a human population]. , 1969, Bulletin of the World Health Organization.

[43]  G. J. Drolet,et al.  Present Trend of Case Fatality Rates in Tuberculosis. , 1938 .